Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of sitagliptin on myocardial performance in coronary artery disease with diabetes
2008-000300-89Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin in coronary arteriosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Left ventricular ejection fraction during dobutamine stress echocardiography. Started Aug 2008; status: completed.
02
Drugs
sitagliptin
03
Conditions
coronary arteriosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-000300-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000300-89.